Share
𝕏 Facebook LinkedIn

Effects of 60 Hz extremely low frequency magnetic fields (EMF) on radiation- and chemical-induced mutagenesis in mammalian cells.

PAPER pubmed Carcinogenesis 2000 In vitro study Effect: no_effect Evidence: Low

Abstract

There is considerable uncertainty of the potential biological effects of extremely low frequency magnetic fields (ELF-MF or EMF) because of mixed results in epidemiological and laboratory studies. In the present study, exponentially growing human-hamster hybrid A(L) cells were treated with a 100 microT alternating EMF powered at 60 Hz for either 24 h or 7 days. Exposure to EMF was conducted either alone or in combination with graded doses of a physical or chemical carcinogen. gamma-radiation was chosen as a form of ionizing radiation while N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) was chosen as a form of chemical contaminant. Exposure of A(L) cells to EMF alone for a period up to 7 days was non-cytotoxic and non-mutagenic. Concurrent EMF treatment did not increase either the cytotoxicity or induction of CD59- mutants by graded doses of gamma-rays or MNNG in A(L) cells. This study shows conclusively that short-term or long-term exposure to EMF alone neither affects the survival of A(L) cells nor increases the mutagenic potency of other environmental carcinogens.

AI evidence extraction

At a glance
Study type
In vitro study
Effect direction
no_effect
Population
Exponentially growing human-hamster hybrid A(L) cells
Sample size
—
Exposure
ELF · 0.06 MHz · 24 h or 7 days
Evidence strength
Low
Confidence: 78% · Peer-reviewed: yes

Main findings

A(L) cells exposed to a 100 microT, 60 Hz alternating magnetic field for up to 7 days showed no cytotoxicity and no increase in mutagenesis. Concurrent EMF exposure did not increase cytotoxicity or CD59- mutant induction from graded doses of gamma-radiation or MNNG.

Outcomes measured

  • Cytotoxicity/survival
  • Mutagenesis (CD59- mutants)
  • Mutagenic potency of gamma-radiation
  • Mutagenic potency of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)

Suggested hubs

  • who-icnirp (0.25)
    Study addresses biological effects of ELF magnetic fields relevant to health risk assessment discussions.
View raw extracted JSON
{
    "study_type": "in_vitro",
    "exposure": {
        "band": "ELF",
        "source": null,
        "frequency_mhz": 0.059999999999999997779553950749686919152736663818359375,
        "sar_wkg": null,
        "duration": "24 h or 7 days"
    },
    "population": "Exponentially growing human-hamster hybrid A(L) cells",
    "sample_size": null,
    "outcomes": [
        "Cytotoxicity/survival",
        "Mutagenesis (CD59- mutants)",
        "Mutagenic potency of gamma-radiation",
        "Mutagenic potency of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)"
    ],
    "main_findings": "A(L) cells exposed to a 100 microT, 60 Hz alternating magnetic field for up to 7 days showed no cytotoxicity and no increase in mutagenesis. Concurrent EMF exposure did not increase cytotoxicity or CD59- mutant induction from graded doses of gamma-radiation or MNNG.",
    "effect_direction": "no_effect",
    "limitations": [],
    "evidence_strength": "low",
    "confidence": 0.7800000000000000266453525910037569701671600341796875,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "extremely low frequency magnetic fields",
        "ELF-MF",
        "60 Hz",
        "100 microT",
        "in vitro",
        "A(L) cells",
        "gamma-radiation",
        "MNNG",
        "mutagenesis",
        "cytotoxicity",
        "CD59 mutants"
    ],
    "suggested_hubs": [
        {
            "slug": "who-icnirp",
            "weight": 0.25,
            "reason": "Study addresses biological effects of ELF magnetic fields relevant to health risk assessment discussions."
        }
    ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.